Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SMA-RTY is a Franco-Italian technology company specializing in advanced artificial intelligence, machine vision, and private standalone 5G networks. Founded in 2019, the company develops modular technologies designed to support institutions and industries in complex, fast-changing environments. Its core offerings include HORUS, an interconnected smart camera system for environmental, industrial, and smart city monitoring, and NGCI (Next-Generation Connectivity Infrastructure), a private 5G network solution. SMA-RTY's technologies are applied across various sectors, including industrial automation, defense, smart cities, and healthcare, where they support tasks such as elderly surveillance and assisted living.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SMA-RTY.